• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 639-653 of 883 results

1156 Exhibit: EX1156 Federal Respondent Oil States

Document IPR2016-01129, No. 1156-238 Exhibit - EX1156 Federal Respondent Oil States (P.T.A.B. Oct. 13, 2017)

cite Cite Document
Analyze

1064 Exhibit: Exhibit 1064 NDA 050790

Document IPR2016-01129, No. 1064-110 Exhibit - Exhibit 1064 NDA 050790 (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

1103 Exhibit: Exhibit 1103 Allergan Inc 2014 10 K

Document IPR2016-01129, No. 1103-149 Exhibit - Exhibit 1103 Allergan Inc 2014 10 K (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

1104 Exhibit: Exhibit 1104 Allergan Q3 2015 Earnings Call

Document IPR2016-01129, No. 1104-150 Exhibit - Exhibit 1104 Allergan Q3 2015 Earnings Call (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

2018 Exhibit: Stern et al, The Pathology of Dry Eye The Interaction Between the Oc...

Document IPR2016-01129, No. 2018-35 Exhibit - Stern et al, The Pathology of Dry Eye The Interaction Between the Ocular Surface and Lacrimal Glands (P.T.A.B. Mar. 20, 2017)

cite Cite Document
Analyze

1042 Exhibit: Exhibit 1042 Calman CV

Document IPR2016-01129, No. 1042-180 Exhibit - Exhibit 1042 Calman CV (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

2060 Exhibit: Allergan Inc AGN Q4 2002 Financial Release Conference CallWednes...

Document IPR2016-01129, No. 2060-64 Exhibit - Allergan Inc AGN Q4 2002 Financial Release Conference CallWednesday, January 29, 2003 1100 am (P.T.A.B. Mar. 20, 2017)

cite Cite Document
Analyze

2009 Exhibit: The Once and Future Treatment of Dry Eye

Document IPR2016-01129, No. 2009-13 Exhibit - The Once and Future Treatment of Dry Eye (P.T.A.B. Sep. 9, 2016)

cite Cite Document
Analyze

1125 Exhibit: PROTECTIVE ORDER MATERIAL Exhibit 1125 AGN RES0734285

Document IPR2016-01129, No. 1125-170 Exhibit - PROTECTIVE ORDER MATERIAL Exhibit 1125 AGN RES0734285 (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

2001 Exhibit: NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 2

Document IPR2016-01129, No. 2001-5 Exhibit - NDA 21 023 Cyclosporine Ophthalmic Emulsion 005 Part 2 (P.T.A.B. Sep. 9, 2016)

cite Cite Document
Analyze

1165 Exhibit: Exhibit 1165 Final Judgment

Document IPR2016-01129, No. 1165-247 Exhibit - Exhibit 1165 Final Judgment (P.T.A.B. Oct. 18, 2017)

cite Cite Document
Analyze

2071 Exhibit: Bradford, Kleit, Nietert, et al, Effects of Direct to Consumer Advertisin...

Document IPR2016-01129, No. 2071-69 Exhibit - Bradford, Kleit, Nietert, et al, Effects of Direct to Consumer Advertising of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors or Attainment of LDL C ...

cite Cite Document
Analyze

1173 Exhibit: Exhibit 1173 Pretrial Conference Hearing Transcript

Document IPR2016-01129, No. 1173-272 Exhibit - Exhibit 1173 Pretrial Conference Hearing Transcript (P.T.A.B. Dec. 14, 2018)

cite Cite Document
Analyze

2017 Exhibit: Schaefer et al, ¿¿¿Skin Permeability,¿¿¿ Springer Verlag 1982

Document IPR2016-01129, No. 2017-34 Exhibit - Schaefer et al, ¿¿¿Skin Permeability,¿¿¿ Springer Verlag 1982 (P.T.A.B. Mar. 20, 2017)

cite Cite Document
Analyze

1106 Exhibit: Exhibit 1106 Allergan Q4 2007 Earnings Call

Document IPR2016-01129, No. 1106-152 Exhibit - Exhibit 1106 Allergan Q4 2007 Earnings Call (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 43 44 45 46 47 ... >>